Brief: Genocea’S Gen-009 Clinical Results Presentation Selected By Asco’S Journal Of Clinical Oncology As A Top 10 Featured Immuno-Oncology Abstract
31/05/2019 13:16
May 31 (Reuters) - Genocea Biosciences Inc GNCA.O :
* GENOCEA’S GEN-009 CLINICAL RESULTS PRESENTATION SELECTED
BY
ASCO’S JOURNAL OF CLINICAL ONCOLOGY AS A TOP 10 FEATURED
IMMUNO-ONCOLOGY ABSTRACT
Source text for Eikon: ID:nGNX54MYl6
Further company coverage: GNCA.O
((Briefs@thomsonreuters.com;))
Recent news on Genocea Biosciences
See all newsBluebird, Chimerix, Clovis have under 6 months of cash left - Truist
Genocea Biosciences plunges as it winds down operations
Brief: Genocea Announces Wind Down Of Operations And Delisting From Nasdaq
Genocea Biosciences Inc reports results for the quarter ended in March - Earnings Summary
U.S. STOCKS ON THE MOVE-Oppenheimer Holdings, IES Holdings Inc, Avantor Inc